Free Trial

Veeva Systems (VEEV) Stock Forecast & Price Target

Veeva Systems logo
$226.10 -2.64 (-1.15%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$225.00 -1.10 (-0.49%)
As of 02/21/2025 05:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Veeva Systems - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
2
Hold
8
Buy
16

Based on 26 Wall Street analysts who have issued ratings for Veeva Systems in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 26 analysts, 2 have given a sell rating, 8 have given a hold rating, and 16 have given a buy rating for VEEV.

Consensus Price Target

$255.08
12.82% Upside
According to the 26 analysts' twelve-month price targets for Veeva Systems, the average price target is $255.08. The highest price target for VEEV is $307.00, while the lowest price target for VEEV is $192.00. The average price target represents a forecasted upside of 12.82% from the current price of $226.10.
Get the Latest News and Ratings for VEEV and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Veeva Systems and its competitors.

Sign Up

VEEV Analyst Ratings Over Time

TypeCurrent Forecast
2/23/24 to 2/22/25
1 Month Ago
1/24/24 to 1/23/25
3 Months Ago
11/25/23 to 11/24/24
1 Year Ago
2/23/23 to 2/23/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
16 Buy rating(s)
17 Buy rating(s)
15 Buy rating(s)
15 Buy rating(s)
Hold
8 Hold rating(s)
8 Hold rating(s)
8 Hold rating(s)
6 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$255.08$253.96$236.92$218.41
Forecasted Upside12.82% Upside13.77% Upside9.39% Upside-1.46% Downside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

VEEV Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

VEEV Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Veeva Systems Stock vs. The Competition

TypeVeeva SystemsMedical CompaniesS&P 500
Consensus Rating Score
2.54
2.82
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside12.82% Upside29,257.95% Upside14.36% Upside
News Sentiment Rating
Positive News

See Recent VEEV News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/23/2025The Goldman Sachs Group
2 of 5 stars
Gabriela Borges
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Sell$261.00 ➝ $200.00-12.68%
1/17/2025Needham & Company LLC
2 of 5 stars
Ryan MacDonald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$270.00 ➝ $270.00+25.76%
1/13/2025Truist Financial
2 of 5 stars
Jailendra Singh
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetHold ➝ Hold$261.00 ➝ $210.00-2.66%
1/8/2025KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$285.00 ➝ $255.00+17.46%
12/20/2024Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Garro
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$280.00+27.46%
12/17/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetUnderweight ➝ Underweight$183.00 ➝ $195.00-12.60%
12/16/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$208.00 ➝ $218.00-4.23%
12/9/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$281.00 ➝ $307.00+22.77%
12/6/2024Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Verkhovski
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetSector Perform ➝ Sector Perform$235.00 ➝ $240.00-4.80%
12/6/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$260.00 ➝ $275.00+9.86%
12/6/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetIn-Line ➝ In-Line$220.00 ➝ $245.00-4.09%
12/6/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$280.00 ➝ $290.00+13.44%
12/6/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$275.00 ➝ $285.00+12.20%
12/6/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$275.00 ➝ $285.00+23.03%
12/6/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$240.00 ➝ $272.00+17.41%
12/6/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$210.00 ➝ $270.00+16.55%
12/6/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$280.00 ➝ $290.00+25.18%
12/6/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$275.00 ➝ $283.00+22.16%
12/4/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Valiquette
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform ➝ Outperform$275.00 ➝ $275.00+21.44%
10/8/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Degasperi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$286.00+41.70%
10/1/2024Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$233.00 ➝ $249.00+20.00%
8/29/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$180.00 ➝ $192.00-11.20%
8/29/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$230.00 ➝ $235.00+12.28%
8/26/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$185.00 ➝ $215.00+7.47%
7/9/2024BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Larsen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$240.00+31.21%
3/4/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$225.00 ➝ $270.00+21.62%
2/22/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$225.00+2.46%
3/2/2023JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Outperform$215.00 ➝ $230.00+38.45%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 08:41 PM ET.


Should I Buy Veeva Systems Stock? VEEV Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, February 20, 2025. Please send any questions or comments about these Veeva Systems pros and cons to contact@marketbeat.com.

Veeva Systems
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Veeva Systems Inc.:

  • Veeva Systems Inc. has a strong market capitalization of approximately $38 billion, indicating a robust financial position and potential for growth.
  • The stock is currently trading at $234.09, which is near its 52-week high of $258.93, suggesting strong investor interest and confidence in the company's performance.
  • Analysts have a consensus rating of "Moderate Buy" for Veeva Systems Inc., with a consensus price target of $253.96, indicating expected appreciation in stock value.
  • Insider ownership stands at 10.50%, which often reflects management's confidence in the company's future and aligns their interests with those of shareholders.
  • Recent upgrades from multiple brokerages, including a price target increase from Canaccord Genuity Group to $270.00, highlight positive sentiment and potential for further stock appreciation.

Veeva Systems
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Veeva Systems Inc. for these reasons:

  • Despite positive ratings, two analysts have issued sell ratings, indicating some skepticism about the stock's future performance.
  • The stock has a high PE ratio of 57.80, which may suggest that it is overvalued compared to its earnings, potentially leading to a price correction.
  • Recent trading activity shows a slight decline in stock price, which could indicate market volatility or investor uncertainty.
  • Veeva Systems Inc. operates in a competitive industry, and any changes in market dynamics or regulatory environments could adversely affect its performance.
  • Some analysts have lowered their price targets, such as Goldman Sachs reducing theirs from $261.00 to $200.00, which may reflect concerns about future growth prospects.

VEEV Forecast - Frequently Asked Questions

According to the research reports of 26 Wall Street equities research analysts, the average twelve-month stock price forecast for Veeva Systems is $255.08, with a high forecast of $307.00 and a low forecast of $192.00.

26 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Veeva Systems in the last twelve months. There are currently 2 sell ratings, 8 hold ratings and 16 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" VEEV shares.

According to analysts, Veeva Systems's stock has a predicted upside of 12.82% based on their 12-month stock forecasts.

Over the previous 90 days, Veeva Systems's stock had 1 downgrade by analysts.

Analysts like Veeva Systems less than other "medical" companies. The consensus rating score for Veeva Systems is 2.54 while the average consensus rating score for "medical" companies is 2.82. Learn more on how VEEV compares to other companies.


This page (NYSE:VEEV) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners